Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Primary Tumor
100%
P14ARF
100%
P16INK4a
100%
Aberrant Methylation
100%
Tumor Subtype
25%
Hypermethylation
25%
Quantitative Methylation-specific PCR (Q-MSP)
12%
Methylation
12%
Molecular Markers
12%
Methylation Status
12%
Human Cancer
12%
Tumor
12%
Upper Tract Urothelial Carcinoma
12%
Medical Records
12%
Worse Prognosis
12%
Poor Prognosis
12%
Breast
12%
Colon
12%
CpG Island
12%
Tumor Protein p53 (TP53)
12%
Tumor Samples
12%
Main Cells
12%
Exon 1
12%
Gene Silencing
12%
Colon Adenocarcinoma
12%
Methylation Changes
12%
Breast Carcinogenesis
12%
Cell Cycle Control
12%
Tumor-normal
12%
Promoter Genes
12%
Promoter Islands
12%
P16INK4a Gene
12%
Bladder Carcinogenesis
12%
INK4a/ARF Locus
12%
Control Pathways
12%
Biochemistry, Genetics and Molecular Biology
Methylation
100%
Prevalence
100%
P14arf
100%
Promoter Region
28%
Colon
28%
Cyclin Dependent Kinase Inhibitor 2A
28%
Carcinogenesis
14%
Exon
14%
Cell Cycle Regulation
14%
Tumor Suppressor Protein
14%
P53
14%
Genetic Marker
14%
CpG Island
14%
Medical Record
14%
P16
14%
Gene Inactivation
14%